Trial analyses: ALS progression slows, survival improves with Radicava ORS
The analyses offer evidence for a slowing of functional decline and improved survival outcomes with long-term Radicava ORS by ALS patients.| ALS News Today
The analyses offer evidence for a slowing of functional decline and improved survival outcomes with long-term Radicava ORS by ALS patients.| ALS News Today
Neither memantine nor trazodone was able to slow amyotrophic lateral sclerosis (ALS) disease progression in a platform clinical trial.| ALS News Today
The activity of "clock genes" that regulate the body’s internal clock, or circadian rhythm, is impaired in Sjögren’s, a mouse model shows.| Sjogren's Syndrome News
The gut microbiome of Parkinson's patients shows substantial functional differences compared with that of healthy people, per a new study.| Parkinson's News Today
Education levels, alcohol intake, not smoking, and a good weight before symptoms manifest may affect Huntington's disease progression.| Huntington's Disease News
